Symbols / DERM $5.04 +2.44% Journey Medical Corporation

Healthcare • Drug Manufacturers - Specialty & Generic • United States • NCM
DERM Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

Journey Medical Corporation, a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topical formulation of minocycline for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris. It also provides Zilxi, a topical minocycline treatment for inflammatory lesions of rosacea; Emrosi for the treatment of inflammatory lesions of rosacea; Exelderm cream and solution for the treatment of fungal skin infections; and Targadox, an oral doxycycline drug for adjunctive therapy for severe acne, as well as Luxamend, a water-based emulsion formulated to provide a moist healing environment for superficial wounds; minor cuts or scrapes; dermal ulcers; donor sites; first- and second-degree burns, including sunburns; and radiation dermatitis. The company was formerly known as Coronado Dermatology, Inc. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona.

Fundamentals
Scroll to Statements
Market Cap 167.61M Enterprise Value 139.05M Income -11.43M Sales 61.86M Book/sh 1.17 Cash/sh 0.88
Dividend Yield — Payout 0.00% Employees 58 IPO — P/E — Forward P/E -84.00
PEG — P/S 2.71 P/B 4.30 P/C — EV/EBITDA -35.53 EV/Sales 2.25
Quick Ratio 1.44 Current Ratio 1.79 Debt/Eq 79.73 LT Debt/Eq — EPS (ttm) -0.47 EPS next Y -0.06
EPS Growth — Revenue Growth 18.10% Earnings 2026-05-14 ROA -5.84% ROE -44.03% ROIC —
Gross Margin 66.17% Oper. Margin -2.76% Profit Margin -18.48% Shs Outstand 21.33M Shs Float 14.84M Short Float 21.70%
Short Ratio 11.36 Short Interest — 52W High 9.55 52W Low 4.31 Beta 1.04 Avg Volume 203.92K
Volume 160.54K Target Price $13.25 Recom Strong_buy Prev Close $4.92 Price $5.04 Change 2.44%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$13.25
Mean price target
2. Current target
$5.04
Latest analyst target
3. DCF / Fair value
$-7.05
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$5.04
Low
$11.00
High
$16.00
Mean
$13.25

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-26 reit HC Wainwright & Co. Buy → Buy $13
2025-08-25 init HC Wainwright & Co. — → Buy $13
2025-08-13 main Lake Street Buy → Buy $13
2025-07-30 main B. Riley Securities Buy → Buy $12
2024-02-16 init Alliance Global Partners — → Buy $9
2023-09-07 reit B. Riley Securities Buy → Buy $6
2023-07-12 main B. Riley Securities Buy → Buy $6
2023-05-23 main B. Riley Securities Buy → Buy $3
2023-03-30 reit B. Riley Securities — → Buy $6
2022-02-25 init Cantor Fitzgerald — → Overweight $9
2021-12-16 init Roth Capital — → Buy $15
2021-12-07 init B. Riley Securities — → Buy $14
News
RSS: Latest DERM news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-08-25 MARAOUI CLAUDE Chief Executive Officer — 1,250,000 $0.06 $81,250
2025-08-05 ROSENWALD LINDSAY A Director — 50,000 $0.00 $0
2025-08-05 PEARCE MICHAEL COOPER Director — 20,000 $0.00 $0
2025-08-05 HERSKOWITZ NEIL Director — 20,000 $0.00 $0
2025-08-05 TOLEDANO MIRANDA JAYNE Director — 20,000 $0.00 $0
2025-08-05 SMITH JUSTIN ADAM Director — 20,000 $0.00 $0
2025-06-25 ROSENWALD LINDSAY A Director — 7,173 $0.00 $0
2025-06-25 PEARCE MICHAEL COOPER Director — 7,173 $0.00 $0
2025-06-25 HERSKOWITZ NEIL Director — 7,173 $0.00 $0
2025-06-25 TOLEDANO MIRANDA JAYNE Director — 7,173 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
61.86
+10.20%
56.13
-29.11%
79.18
+7.48%
73.67
Operating Revenue
61.24
+11.07%
55.13
-7.59%
59.66
-15.96%
71.00
Cost Of Revenue
20.92
+0.22%
20.88
-8.80%
22.89
-25.61%
30.77
Reconciled Cost Of Revenue
20.84
+0.23%
20.79
-8.84%
22.80
-25.90%
30.77
Gross Profit
40.93
+16.11%
35.26
-37.37%
56.29
+31.23%
42.89
Operating Expense
49.11
-8.19%
53.48
-3.14%
55.22
-21.58%
70.41
Research And Development
0.48
-95.13%
9.86
+30.71%
7.54
-31.09%
10.94
Selling General And Administration
44.37
+10.36%
40.20
-8.44%
43.91
-26.16%
59.47
Total Expenses
70.03
-5.83%
74.36
-4.80%
78.11
-22.80%
101.19
Operating Income
-8.17
+55.17%
-18.23
-1803.74%
1.07
+103.89%
-27.52
Total Operating Income As Reported
-8.17
+40.25%
-13.68
-559.77%
-2.07
+92.47%
-27.52
EBITDA
-3.33
+60.37%
-8.40
-537.06%
1.92
+108.29%
-23.18
Normalized EBITDA
-3.24
+76.81%
-13.96
-366.02%
5.25
+122.72%
-23.09
Reconciled Depreciation
4.35
+23.64%
3.52
-8.82%
3.85
-11.68%
4.37
EBIT
-7.67
+35.58%
-11.91
-515.87%
-1.93
+92.98%
-27.55
Total Unusual Items
-0.09
-101.62%
5.56
+267.23%
-3.33
-3637.08%
-0.09
Total Unusual Items Excluding Goodwill
-0.09
-101.62%
5.56
+267.23%
-3.33
-3637.08%
-0.09
Special Income Charges
0.00
-100.00%
5.68
+280.66%
-3.14
0.00
Other Special Charges
—
-5.68
—
—
Impairment Of Capital Assets
—
0.00
-100.00%
3.14
0.00
Net Income
-11.43
+22.09%
-14.67
-280.79%
-3.85
+87.00%
-29.63
Pretax Income
-11.37
+22.18%
-14.61
-302.29%
-3.63
+87.72%
-29.57
Net Non Operating Interest Income Expense
-3.11
-60.01%
-1.94
-41.21%
-1.38
+29.76%
-1.96
Interest Expense Non Operating
3.70
+36.96%
2.70
+59.01%
1.70
-15.90%
2.02
Net Interest Income
-3.11
-60.01%
-1.94
-41.21%
-1.38
+29.76%
-1.96
Interest Expense
3.70
+36.96%
2.70
+59.01%
1.70
-15.90%
2.02
Interest Income Non Operating
0.59
-22.19%
0.76
+135.09%
0.32
+436.67%
0.06
Interest Income
0.59
-22.19%
0.76
+135.09%
0.32
+436.67%
0.06
Other Income Expense
-0.09
-101.62%
5.56
+267.23%
-3.33
-3637.08%
-0.09
Gain On Sale Of Security
-0.09
+22.41%
-0.12
+36.61%
-0.18
-105.62%
-0.09
Tax Provision
0.06
-1.64%
0.06
-72.40%
0.22
+250.79%
0.06
Tax Rate For Calcs
0.00
+0.00%
0.00
+0.00%
0.00
0.00
Tax Effect Of Unusual Items
-0.02
-101.62%
1.17
+267.23%
-0.70
0.00
Net Income Including Noncontrolling Interests
-11.43
+22.09%
-14.67
-280.79%
-3.85
+87.00%
-29.63
Net Income From Continuing Operation Net Minority Interest
-11.43
+22.09%
-14.67
-280.79%
-3.85
+87.00%
-29.63
Net Income From Continuing And Discontinued Operation
-11.43
+22.09%
-14.67
-280.79%
-3.85
+87.00%
-29.63
Net Income Continuous Operations
-11.43
+22.09%
-14.67
-280.79%
-3.85
+87.00%
-29.63
Normalized Income
-11.36
+40.42%
-19.07
-1455.82%
-1.23
+95.85%
-29.54
Net Income Common Stockholders
-11.43
+22.09%
-14.67
-280.79%
-3.85
+87.00%
-29.63
Diluted EPS
—
-0.72
-242.86%
-0.21
+87.57%
-1.69
Basic EPS
—
-0.72
-242.86%
-0.21
+87.57%
-1.69
Basic Average Shares
—
20.43
+12.06%
18.23
+4.00%
17.53
Diluted Average Shares
—
20.43
+12.06%
18.23
+4.00%
17.53
Diluted NI Availto Com Stockholders
-11.43
+22.09%
-14.67
-280.79%
-3.85
+87.00%
-29.63
Amortization
4.26
+24.36%
3.42
-9.11%
3.77
—
Amortization Of Intangibles Income Statement
4.26
+24.36%
3.42
-9.11%
3.77
—
Depreciation Amortization Depletion Income Statement
4.26
+24.36%
3.42
-9.11%
3.77
—
Depreciation And Amortization In Income Statement
4.26
+24.36%
3.42
-9.11%
3.77
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
94.59
+17.88%
80.24
+4.41%
76.85
-26.92%
105.16
Current Assets
66.87
+38.80%
48.18
-14.66%
56.45
-27.32%
77.68
Cash Cash Equivalents And Short Term Investments
24.09
+18.64%
20.30
-26.00%
27.44
-14.26%
32.00
Cash And Cash Equivalents
24.09
+18.64%
20.30
-26.00%
27.44
-14.26%
32.00
Receivables
29.78
+191.11%
10.23
-32.79%
15.22
-46.04%
28.21
Accounts Receivable
29.78
+191.11%
10.23
-32.79%
15.22
-46.04%
28.21
Gross Accounts Receivable
29.98
+176.83%
10.83
-31.11%
15.72
-45.04%
28.61
Allowance For Doubtful Accounts Receivable
-0.20
+66.67%
-0.60
-20.00%
-0.50
-25.00%
-0.40
Inventory
9.62
-33.31%
14.43
+41.40%
10.21
-27.92%
14.16
Raw Materials
3.06
-4.35%
3.20
-31.12%
4.64
-28.11%
6.45
Work In Process
0.17
-52.59%
0.37
-58.48%
0.88
+123.80%
0.40
Finished Goods
7.39
-35.08%
11.38
+128.21%
4.99
-35.56%
7.74
Prepaid Assets
—
—
—
—
Other Current Assets
3.38
+5.11%
3.21
-10.48%
3.59
+8.43%
3.31
Total Non Current Assets
27.72
-13.55%
32.06
+57.21%
20.39
-25.79%
27.48
Net PPE
0.11
-44.22%
0.20
+97.03%
0.10
-46.56%
0.19
Gross PPE
0.11
-44.22%
0.20
+97.03%
0.10
-46.56%
0.19
Other Properties
0.11
-44.22%
0.20
+97.03%
0.10
-46.56%
0.19
Goodwill And Other Intangible Assets
27.61
-13.36%
31.86
+57.06%
20.29
-25.41%
27.20
Other Intangible Assets
27.61
-13.36%
31.86
+57.06%
20.29
-25.41%
27.20
Non Current Deferred Assets
—
—
—
—
Non Current Deferred Taxes Assets
—
—
—
—
Other Non Current Assets
—
—
0.01
-93.68%
0.10
Total Liabilities Net Minority Interest
62.74
+4.26%
60.17
+6.50%
56.50
-35.93%
88.18
Current Liabilities
37.44
+6.44%
35.17
-15.99%
41.87
-37.35%
66.83
Payables And Accrued Expenses
29.57
+5.76%
27.96
-9.67%
30.96
-37.72%
49.71
Payables
11.18
-37.92%
18.01
-11.76%
20.41
-48.51%
39.65
Accounts Payable
8.85
-44.85%
16.05
-11.57%
18.15
-50.93%
36.98
Other Payable
1.80
+31.37%
1.37
-31.81%
2.02
-23.30%
2.63
Current Accrued Expenses
18.39
+84.81%
9.95
-5.62%
10.55
+4.82%
10.06
Pensionand Other Post Retirement Benefit Plans Current
5.59
+65.45%
3.38
+0.12%
3.37
+30.47%
2.59
Total Tax Payable
0.07
+16.67%
0.06
+13.21%
0.05
+51.43%
0.04
Income Tax Payable
0.07
+16.67%
0.06
+13.21%
0.05
+51.43%
0.04
Current Debt And Capital Lease Obligation
0.10
+21.69%
0.08
-16.16%
0.10
-96.73%
3.03
Current Debt
—
—
—
2.95
Current Capital Lease Obligation
0.10
+21.69%
0.08
-16.16%
0.10
+19.28%
0.08
Current Deferred Liabilities
—
—
0.00
-100.00%
4.99
Other Current Liabilities
—
0.62
-81.40%
3.36
+18.77%
2.83
Total Non Current Liabilities Net Minority Interest
25.30
+1.19%
25.00
+70.85%
14.63
-31.46%
21.35
Long Term Debt And Capital Lease Obligation
25.30
+1.19%
25.00
+70.85%
14.63
-26.60%
19.93
Long Term Debt
25.28
+1.60%
24.88
+70.15%
14.62
-26.25%
19.83
Long Term Capital Lease Obligation
0.02
-84.75%
0.12
+1211.11%
0.01
-91.67%
0.11
Tradeand Other Payables Non Current
—
—
—
—
Other Non Current Liabilities
—
—
—
1.41
Stockholders Equity
31.85
+58.71%
20.07
-1.38%
20.35
+19.83%
16.98
Common Stock Equity
31.85
+58.71%
20.07
-1.38%
20.35
+19.83%
16.98
Capital Stock
0.00
+50.00%
0.00
+0.00%
0.00
+0.00%
0.00
Common Stock
0.00
+50.00%
0.00
+0.00%
0.00
+0.00%
0.00
Share Issued
27.14
+22.53%
22.15
+14.64%
19.32
+8.77%
17.77
Ordinary Shares Number
27.14
+22.53%
22.15
+14.64%
19.32
+8.77%
17.77
Additional Paid In Capital
130.31
+21.68%
107.09
+15.52%
92.70
+8.45%
85.48
Retained Earnings
-98.46
-13.14%
-87.03
-20.28%
-72.36
-5.62%
-68.50
Total Equity Gross Minority Interest
31.85
+58.71%
20.07
-1.38%
20.35
+19.83%
16.98
Total Capitalization
57.13
+27.10%
44.95
+28.53%
34.97
-4.99%
36.81
Working Capital
29.43
+126.32%
13.00
-10.85%
14.59
+34.48%
10.85
Invested Capital
57.13
+27.10%
44.95
+28.53%
34.97
-12.03%
39.76
Total Debt
25.40
+1.26%
25.08
+70.26%
14.73
-35.86%
22.96
Net Debt
1.19
-74.05%
4.57
—
—
Capital Lease Obligations
0.12
-40.80%
0.20
+86.11%
0.11
-43.46%
0.19
Net Tangible Assets
4.25
+136.01%
-11.79
-18820.63%
0.06
+100.62%
-10.21
Tangible Book Value
4.25
+136.01%
-11.79
-18820.63%
0.06
+100.62%
-10.21
Current Provisions
2.18
-30.31%
3.12
-23.38%
4.08
+10.52%
3.69
Dueto Related Parties Current
0.46
-13.83%
0.53
+170.77%
0.20
-52.78%
0.41
Interest Payable
0.40
-1.49%
0.40
+1736.36%
0.02
-86.25%
0.16
Inventories Adjustments Allowances
-1.00
-94.15%
-0.51
-68.20%
-0.30
+28.90%
-0.43
Line Of Credit
—
—
0.00
-100.00%
2.95
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-12.44
-36.31%
-9.13
-274.18%
5.24
+138.72%
-13.53
Cash Flow From Continuing Operating Activities
-12.44
-36.31%
-9.13
-274.18%
5.24
+138.72%
-13.53
Net Income From Continuing Operations
-11.43
+22.09%
-14.67
-280.79%
-3.85
+87.00%
-29.63
Depreciation Amortization Depletion
4.35
+23.64%
3.52
-8.82%
3.85
-11.68%
4.37
Depreciation
0.09
-3.30%
0.09
+3.41%
0.09
+0.00%
0.09
Amortization Cash Flow
4.26
+24.36%
3.42
-9.11%
3.77
-11.92%
4.28
Depreciation And Amortization
4.35
+23.64%
3.52
-8.82%
3.85
-11.68%
4.37
Amortization Of Intangibles
4.26
+24.36%
3.42
-9.11%
3.77
-11.92%
4.28
Other Non Cash Items
0.47
+51.79%
0.31
-56.70%
0.71
-14.89%
0.83
Stock Based Compensation
6.29
+3.12%
6.10
+134.00%
2.61
-41.11%
4.42
Asset Impairment Charge
-0.21
-140.89%
0.52
-85.58%
3.58
+1159.86%
0.28
Deferred Tax
—
—
—
0.00
Deferred Income Tax
—
—
—
0.00
Operating Gains Losses
—
-1.12
—
—
Gain Loss On Investment Securities
—
—
—
—
Change In Working Capital
-11.90
-215.96%
-3.77
-127.55%
-1.66
-126.75%
6.19
Change In Receivables
-19.34
-532.20%
4.47
-64.35%
12.55
+333.29%
-5.38
Changes In Account Receivables
-19.34
-532.20%
4.47
-64.35%
12.55
+333.29%
-5.38
Change In Inventory
4.81
+213.78%
-4.22
-206.88%
3.95
+126.66%
1.74
Change In Prepaid Assets
-0.16
-143.62%
0.38
+234.77%
-0.28
+67.97%
-0.87
Change In Payables And Accrued Expense
2.88
+166.97%
-4.30
+75.83%
-17.80
-265.80%
10.73
Change In Accrued Expense
10.07
+555.66%
-2.21
-464.69%
0.61
+116.67%
-3.64
Change In Payable
-7.19
-243.64%
-2.09
+88.63%
-18.40
-228.07%
14.37
Change In Account Payable
-7.20
-242.97%
-2.10
+88.61%
-18.42
-228.43%
14.34
Change In Other Current Assets
0.00
-100.00%
0.01
0.00
-100.00%
0.06
Change In Other Current Liabilities
-0.08
+14.58%
-0.10
-15.66%
-0.08
+12.63%
-0.10
Investing Cash Flow
0.00
+100.00%
-15.00
-200.00%
-5.00
+75.00%
-20.00
Cash Flow From Continuing Investing Activities
0.00
+100.00%
-15.00
-200.00%
-5.00
+75.00%
-20.00
Capital Expenditure
—
-15.00
-200.00%
-5.00
+75.00%
-20.00
Net Intangibles Purchase And Sale
0.00
+100.00%
-15.00
-200.00%
-5.00
+75.00%
-20.00
Purchase Of Intangibles
0.00
+100.00%
-15.00
-200.00%
-5.00
+75.00%
-20.00
Net Other Investing Changes
—
—
—
-20.00
Financing Cash Flow
16.23
-4.51%
16.99
+453.73%
-4.80
-129.19%
16.46
Cash Flow From Continuing Financing Activities
16.23
-4.51%
16.99
+453.73%
-4.80
-129.19%
16.46
Net Issuance Payments Of Debt
15.73
-5.37%
16.63
+473.30%
-4.45
-126.36%
16.90
Issuance Of Debt
16.36
-8.49%
17.88
-62.36%
47.49
+91.79%
24.76
Repayment Of Debt
-0.62
+50.00%
-1.25
+97.59%
-51.95
-560.58%
-7.86
Long Term Debt Issuance
16.36
-8.49%
17.88
-8.29%
19.49
-1.36%
19.76
Long Term Debt Payments
-0.62
+50.00%
-1.25
+94.05%
-21.00
-320.00%
-5.00
Net Long Term Debt Issuance
15.73
-5.37%
16.63
+1204.05%
-1.51
-110.20%
14.76
Short Term Debt Issuance
—
0.00
-100.00%
28.00
+460.00%
5.00
Short Term Debt Payments
—
0.00
+100.00%
-30.95
-980.59%
-2.86
Net Short Term Debt Issuance
—
0.00
+100.00%
-2.95
-238.01%
2.14
Net Common Stock Issuance
—
—
4.49
0.00
Proceeds From Stock Option Exercised
0.57
+36.30%
0.42
+243.80%
0.12
-14.79%
0.14
Net Other Financing Charges
-0.07
-50.00%
-0.05
+89.38%
-0.47
+19.49%
-0.58
Changes In Cash
3.79
+153.06%
-7.13
-56.31%
-4.56
+73.28%
-17.08
Beginning Cash Position
20.30
-26.00%
27.44
-14.26%
32.00
-34.80%
49.08
End Cash Position
24.09
+18.64%
20.30
-26.00%
27.44
-14.26%
32.00
Free Cash Flow
-12.44
+48.44%
-24.13
-10152.92%
0.24
+100.72%
-33.53
Interest Paid Supplemental Data
3.24
+61.01%
2.01
+78.44%
1.13
+13.49%
0.99
Income Tax Paid Supplemental Data
0.05
-60.00%
0.12
-30.94%
0.18
+7.74%
0.17
Change In Income Tax Payable
0.01
+42.86%
0.01
-61.11%
0.02
-33.33%
0.03
Change In Interest Payable
-0.01
-101.57%
0.38
+376.81%
-0.14
-186.25%
0.16
Change In Tax Payable
0.01
+42.86%
0.01
-61.11%
0.02
-33.33%
0.03
Common Stock Issuance
—
—
4.49
0.00
Issuance Of Capital Stock
—
—
4.49
0.00
Net Preferred Stock Issuance
—
—
—
0.00
Preferred Stock Issuance
—
—
—
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category